The e-psychonaut drugs’ psychopharmacology

Schifano, Fabrizio; Chiappini, Stefania; Corkery, John M.; Scherbaum, Norbert; Guirguis, Amira

doi:10.1016/j.coph.2021.02.008

Journal article 934 views 321 downloads

The e-psychonaut drugs’ psychopharmacology

Fabrizio Schifano, Stefania Chiappini, John M. Corkery, Norbert Scherbaum, Amira Guirguis

Current Opinion in Pharmacology, Volume: 57, Pages: 165 - 174

Swansea University Author: Amira Guirguis

PDF | Accepted Manuscript

©2021 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND)
Download (184.83KB)

Check full text

DOI (Published version): 10.1016/j.coph.2021.02.008

Abstract

The focus here was on the pharmacological and clinical pharmacological issues pertaining to the vast range of drugs (e.g., synthetic cannabimimetics; synthetic opioids; novel stimulants; novel psychedelics; PCP/ketamine-like compounds; prescribed medicinal compounds; and popular psychotropic herbs/p...

Full description

Published in:	Current Opinion in Pharmacology
ISSN:	1471-4892
Published:	UK Elsevier BV 2021
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa56315
Tags:	Add Tag No Tags, Be the first to tag this record!

first_indexed	2021-02-24T12:21:23Z
last_indexed	2021-08-14T03:20:12Z
id	cronfa56315
recordtype	SURis
fullrecord	<?xml version="1.0"?><rfc1807><datestamp>2021-08-13T13:10:56.3484848</datestamp><bib-version>v2</bib-version><id>56315</id><entry>2021-02-24</entry><title>The e-psychonaut drugs’ psychopharmacology</title><swanseaauthors><author><sid>b49270b9a0d580cf4f31f9a1b6c93f87</sid><ORCID>0000-0001-8255-0660</ORCID><firstname>Amira</firstname><surname>Guirguis</surname><name>Amira Guirguis</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2021-02-24</date><deptcode>PHAR</deptcode><abstract>The focus here was on the pharmacological and clinical pharmacological issues pertaining to the vast range of drugs (e.g., synthetic cannabimimetics; synthetic opioids; novel stimulants; novel psychedelics; PCP/ketamine-like compounds; prescribed medicinal compounds; and popular psychotropic herbs/plants) discussed by Internet-based, new/novel psychoactive substances (NPS) enthusiasts, ‘e-psychonauts’.Currently ongoing related in silico studies, followed by further in vitro and in vivo/preclinical studies, will hopefully provide important findings in terms of which molecules within each given NPS class may present with higher levels of receptor affinities, and hence clinical potency. Understanding the pharmacological characteristics/potency of those novel recreational molecules will hopefully help in predicting related NPS diffusion, morbidity, and possible lethality data.</abstract><type>Journal Article</type><journal>Current Opinion in Pharmacology</journal><volume>57</volume><journalNumber/><paginationStart>165</paginationStart><paginationEnd>174</paginationEnd><publisher>Elsevier BV</publisher><placeOfPublication>UK</placeOfPublication><isbnPrint/><isbnElectronic/><issnPrint>1471-4892</issnPrint><issnElectronic/><keywords>e-psychonauts; psychopharmacology; addiction; new psychoactive substances; novel psychoactive substances; NPS; drug abuse</keywords><publishedDay>1</publishedDay><publishedMonth>4</publishedMonth><publishedYear>2021</publishedYear><publishedDate>2021-04-01</publishedDate><doi>10.1016/j.coph.2021.02.008</doi><url/><notes/><college>COLLEGE NANME</college><department>Pharmacy</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>PHAR</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-08-13T13:10:56.3484848</lastEdited><Created>2021-02-24T12:12:59.1510234</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Fabrizio</firstname><surname>Schifano</surname><order>1</order></author><author><firstname>Stefania</firstname><surname>Chiappini</surname><order>2</order></author><author><firstname>John M.</firstname><surname>Corkery</surname><order>3</order></author><author><firstname>Norbert</firstname><surname>Scherbaum</surname><order>4</order></author><author><firstname>Amira</firstname><surname>Guirguis</surname><orcid>0000-0001-8255-0660</orcid><order>5</order></author></authors><documents><document><filename>56315__19465__87a88d1e01104082a6a08a07dbfd091a.pdf</filename><originalFilename>56315.pdf</originalFilename><uploaded>2021-03-10T13:18:20.9674392</uploaded><type>Output</type><contentLength>189264</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2022-03-25T00:00:00.0000000</embargoDate><documentNotes>©2021 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND)</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by-nc-nd/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling	2021-08-13T13:10:56.3484848 v2 56315 2021-02-24 The e-psychonaut drugs’ psychopharmacology b49270b9a0d580cf4f31f9a1b6c93f87 0000-0001-8255-0660 Amira Guirguis Amira Guirguis true false 2021-02-24 PHAR The focus here was on the pharmacological and clinical pharmacological issues pertaining to the vast range of drugs (e.g., synthetic cannabimimetics; synthetic opioids; novel stimulants; novel psychedelics; PCP/ketamine-like compounds; prescribed medicinal compounds; and popular psychotropic herbs/plants) discussed by Internet-based, new/novel psychoactive substances (NPS) enthusiasts, ‘e-psychonauts’.Currently ongoing related in silico studies, followed by further in vitro and in vivo/preclinical studies, will hopefully provide important findings in terms of which molecules within each given NPS class may present with higher levels of receptor affinities, and hence clinical potency. Understanding the pharmacological characteristics/potency of those novel recreational molecules will hopefully help in predicting related NPS diffusion, morbidity, and possible lethality data. Journal Article Current Opinion in Pharmacology 57 165 174 Elsevier BV UK 1471-4892 e-psychonauts; psychopharmacology; addiction; new psychoactive substances; novel psychoactive substances; NPS; drug abuse 1 4 2021 2021-04-01 10.1016/j.coph.2021.02.008 COLLEGE NANME Pharmacy COLLEGE CODE PHAR Swansea University 2021-08-13T13:10:56.3484848 2021-02-24T12:12:59.1510234 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Fabrizio Schifano 1 Stefania Chiappini 2 John M. Corkery 3 Norbert Scherbaum 4 Amira Guirguis 0000-0001-8255-0660 5 56315__19465__87a88d1e01104082a6a08a07dbfd091a.pdf 56315.pdf 2021-03-10T13:18:20.9674392 Output 189264 application/pdf Accepted Manuscript true 2022-03-25T00:00:00.0000000 ©2021 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND) true eng http://creativecommons.org/licenses/by-nc-nd/4.0/
title	The e-psychonaut drugs’ psychopharmacology
spellingShingle	The e-psychonaut drugs’ psychopharmacology Amira Guirguis
title_short	The e-psychonaut drugs’ psychopharmacology
title_full	The e-psychonaut drugs’ psychopharmacology
title_fullStr	The e-psychonaut drugs’ psychopharmacology
title_full_unstemmed	The e-psychonaut drugs’ psychopharmacology
title_sort	The e-psychonaut drugs’ psychopharmacology
author_id_str_mv	b49270b9a0d580cf4f31f9a1b6c93f87
author_id_fullname_str_mv	b49270b9a0d580cf4f31f9a1b6c93f87_***_Amira Guirguis
author	Amira Guirguis
author2	Fabrizio Schifano Stefania Chiappini John M. Corkery Norbert Scherbaum Amira Guirguis
format	Journal article
container_title	Current Opinion in Pharmacology
container_volume	57
container_start_page	165
publishDate	2021
institution	Swansea University
issn	1471-4892
doi_str_mv	10.1016/j.coph.2021.02.008
publisher	Elsevier BV
college_str	Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id	facultyofmedicinehealthandlifesciences
hierarchy_top_title	Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id	facultyofmedicinehealthandlifesciences
hierarchy_parent_title	Faculty of Medicine, Health and Life Sciences
department_str	Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str	1
active_str	0
description	The focus here was on the pharmacological and clinical pharmacological issues pertaining to the vast range of drugs (e.g., synthetic cannabimimetics; synthetic opioids; novel stimulants; novel psychedelics; PCP/ketamine-like compounds; prescribed medicinal compounds; and popular psychotropic herbs/plants) discussed by Internet-based, new/novel psychoactive substances (NPS) enthusiasts, ‘e-psychonauts’.Currently ongoing related in silico studies, followed by further in vitro and in vivo/preclinical studies, will hopefully provide important findings in terms of which molecules within each given NPS class may present with higher levels of receptor affinities, and hence clinical potency. Understanding the pharmacological characteristics/potency of those novel recreational molecules will hopefully help in predicting related NPS diffusion, morbidity, and possible lethality data.
published_date	2021-04-01T04:11:10Z
_version_	1763753770052747264
score	11.037056

The e-psychonaut drugs’ psychopharmacology

Similar Items